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Background: Neuropsychiatric symptoms play an important role in diagnosing and clinical 
follow-up of cognitive impairment and dementia.
Objective: We investigated the relationship between neuropsychiatric symptoms, cognitive 
impairment, and dementia in Hispanics.
Methods: We included 529 participants (age ≥40 years) from the Maracaibo Aging Study with 
standardized neuropsychiatric assessments, including the Neuropsychiatric Inventory (NPI). Based 
on the Clinical Dementia Rating and the Mini-Mental State Examination scores, participants’ 
cognitive status was categorized into normal cognition, mild/moderate, and severe cognitive 
impairment. Diagnosis of dementia was established in a consensus conference. Statistical analyses 
included multivariable logistic regression models and area under the curve (AUC).
Results: The mean age of participants was 59.3 years, and 71.8% were women. The 
proportion of dementia was 6.8%. Disturbed sleep, anxiety, and depression were the most 
common neuropsychiatric symptoms in the study sample. In crude analyses, the proportions of 
hallucinations, aberrant motor behavior, agitation/aggression, apathy, delusions, irritability, eating 
disturbance, depression, and euphoria were differently distributed among cognitive status groups 
(p < 0.05). After accounting for confounders, aberrant motor behavior and agitation/aggression 
remained significantly associated with cognitive impairment and dementia (p < 0.05). The 
inclusion of the NPI domains significantly improved the AUC to discriminate severe cognitive 
impairment and dementia above of a basic model that included sex, age, education, alcohol, 
obesity, serum glucose, total cholesterol, hypertension, and stroke.
Conclusion: Neuropsychiatric symptoms are associated with severe cognitive impairment and 
dementia. The addition of NPI items to the global cognitive assessment might help early detection 
of dementia in primary care settings.
Keywords
Aging; Alzheimer’s disease; cognitive impairment; dementia; hispanics; neuropsychiatric 
inventory
INTRODUCTION
Alzheimer’s disease (AD) and related dementias represent a major global health challenge 
problem in older adults, with 40–50 million people currently living with dementia. In 
addition, given the increased global longevity, communities, governments, and healthcare 
systems are facing an exacerbated burden of dementias [1]. This situation demands 
prevention strategies targeted to identify risk factors in the early stages of dementia that 
delay the onset and reduce the poor outcomes associated with the disease’s clinical course. 
To achieve this, the cognitive changes resembling “normal aging” and denoting dementia 
onset should be properly differentiated [2]. The first line diagnostic evaluation is usually 
primary care providers which rely on global cognitive assessment tools and short anamnesis 
to collect information about the impact of cognitive changes on daily life activities to 
determine whether further clinical assessment is needed. However, very frequently, this 
information is not sufficient to properly identify cognitive decline and/or dementia. Because 
of improved diagnostic accuracy [3, 4] and prediction of outcomes in patients with dementia 
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[5], recognizing neuropsychiatric symptoms may be a valuable step in the primary care of 
older adults.
The deficiency of clinical tools and the poorly understood race/ethnicity differences in 
the epidemiology of dementias aggravates the diagnostic needs in low resource settings. 
Hispanics are disproportionately affected by AD, with almost a two-fold elevated risk of 
developing AD [6, 7] and earlier onset of the disease than non-Hispanic whites [8]. Yet 
Hispanics are underrepresented in clinical research [9], leading to a lack of information 
regarding the clinical course of dementia in this rapidly growing minority group. Given the 
current gaps in the literature about dementia in Hispanics living in developing countries, 
and the need for tackling early detection of dementia, we conducted the present study 
to investigate the relationship of neuropsychiatric symptoms with cognitive impairment 
and dementia in a population-based study of older Hispanic adults living in Maracaibo 
City, Venezuela. Moreover, we tested the hypothesis that the inclusion of neuropsychiatric 
information improves the sensitivity of a global cognitive assessment such as the Mini­




The Maracaibo Aging Study (MAS) is a longitudinal, prospective, community-based, 
cohort study of individuals, ≥40 years old, residing in the Santa Lucia and Santa Rosa 
neighborhoods, Maracaibo, Venezuela. The MAS initially included 2,439 subjects ≥55 
years old, living in the community of Santa Lucia from 1998 to 2001, which were 
followed until 2016, undergoing the same standardized assessments. In 2011, the MAS 
was expanded to include 420 participants, ≥40 years old, living in Santa Rosa de Agua and 
109 residing in Santa Lucía; the distance between the two communities is approximately 
6 km. These two samples are relatively stable communities with a high density of 
families of different socioeconomic conditions [10]. The MAS collected information about 
demographic, clinical, nutritional, cardiovascular, cognitive, and social factors associated 
with aging. For the present study, we included the 529 subjects recruited in 2011 with 
available baseline data on the Neuropsychiatric Inventory (NPI) and cognitive evaluations, 
including dementia assessment and MMSE. Detailed information regarding recruitment 
strategy, study design, and sample characteristics have been previously reported [10, 11]. 
Informed consent was obtained for each participant or from a surrogate when appropriate. 
The Institutional Review Board of the Cardiovascular Center at the University of Zulia in 
Maracaibo approved the study.
Assessment of behavioral symptoms
The NPI rates each dementia-related behavioral symptom according to frequency (0—4 
points), and severity (1–3 points), and the total score is calculated by multiplying the 
frequency × severity [12]. The scores scale from 0 to 12 points. Eighty-two participants 
(16.1%) were not able to respond to the NPI inquiries and a family member or 
a caregiver provided the information about the presence, frequency, and severity of 
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behavioral symptoms. Trained psychiatrists conducted the NPI interview. The NPI domains 
included delusions, hallucinations, agitation/aggression, depression, anxiety, euphoria, 
apathy, disinhibition, irritability, aberrant motor behavior, sleep disturbances, and eating 
disturbances [12]. Subjects with an NPI score of zero were classified as “asymptomatic”, 
whereas those with NPI scores ≥ 1 were classified as “symptomatic”.
Cognitive assessment and dementia diagnoses
Cognitive performance was assessed using the MMSE [13], and cognitive domains were 
assessed using a full neuropsychological battery of cognitive tests administered by a 
neuropsychologist [10]. The original MMSE has a maximum score of 30 points [14]. The 
MMSE scores were divided into normal (24–30 points), low (18–23 points), and very-low 
MMSE scores (≤17 points). We therefore categorized cognitive status by combining the 
MMSE and the CDR scores (0.0, 0.5, 1.0, 2.0, and 3.0) [30]. We included both measures as 
individuals with normal or low MMSE scores can have CDR scores between 0.0 and ≥1.0 
(Supplementary Table 1). A total of 360 participants were identified with normal cognitive 
status, 98 mild-cognitive impairment, and 71 with severe cognitive impairment.
Diagnoses of dementia were made by consensus during a conference of physicians, 
psychologists, and social workers, who discussed all ancillary information and followed 
the diagnostic strategy developed for the Washington Heights-Inwood Columbia Aging 
Project in New York [19]. Besides having a CDR score of 1 or higher to define dementia 
[30], individuals had cognitive impairment resulting in a functional decline in their social 
or occupational activities from their previous level of functioning, not explained by 
other conditions. Dementia diagnoses were classified as AD, Vascular dementia, or other 
dementia, based on standardized criteria for each illness in the Diagnostic and Statistical 
Manual of Mental Disorders (4th Edition) and specific criteria for each dementia subtype 
[15]. MMSE scores are significantly associated to the diagnosis of dementia (Supplementary 
Table 2).
Statistical analyses
Descriptive information is presented as mean ± standard deviation, and frequency as a 
percentage (%). We calculated the relative frequency of NPI symptoms according to 
cognitive status and dementia, and a between-group comparison was made with the Chi­
square test. The contrast between groups for continuous variables was made with analysis 
of variance (ANOVA) followed by Tukey post-hoc test. To define the independence among 
NPI items, we used a principal component factor analysis with Oblimin rotation and Kaiser 
normalization; components were based on a loading of 0.5 or greater. To determine the 
association of each of the NPI symptoms with cognitive status, two logistic regression 
models were designed (normal versus mild/moderate cognitive impairment, and normal 
versus severe cognitive impairment). The models used the cognitive status (Mild/Moderate 
or Severe Cognitive Impairment) as the exposure/dependent variable and the presence/
absence of each NPI symptom as the independent variable adjusted by sex, age, education, 
alcohol habits, obesity, serum glucose levels, serum total cholesterol levels, previous stroke, 
and conventional hypertension. The selection of covariables was based on the comparison of 
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clinical characteristics among categories of cognitive status, and variables with a p-value ≤ 
0.15 were selected as potential confounders.
We conducted a receiver-operating characteristic curve analysis to determine the area 
under the curve (AUC) to discriminate between participants with normal cognitive status 
versus those with mild/moderate-and severe cognitive impairment, and participants with 
and without dementia. Two models were designed, the basic model that accounted for sex, 
age, education, alcohol habits, obesity, serum glucose levels, serum total cholesterol levels, 
previous stroke, and conventional hypertension, and the second model included in addition 
to potential confounders, the NPI symptoms. Statistical analyses were performed using 
SPSS software, and statistical significance was accepted at p < 0.05.
RESULTS
Demographic characteristics
Table 1 lists the characteristics of the 529 participants included in the present study. 
The mean age was 59.3 years old, and 71.8% (n = 380) of participants were women. 
The proportion of dementia was 6.8% (n = 36). Across categories of cognitive status 
(from normal, mild/moderate, and severe cognitive status), individuals with severe cognitive 
impairment were 13 years older than those with normal cognition (p = 0.029), had 7 years 
less of education (p < 0.001), had lower proportions of alcohol habits (p < 0.001) and 
obesity (p = 0.025), higher serum levels of glucose and total cholesterol (p < 0.05). The 
proportions of women (p < 0.001) and conventional hypertension (p = 0.021) were higher. 
Over 50% of individuals with severe cognitive impairment also had a dementia diagnosis, 
whereas no individuals had this diagnosis in the other cognitive categories (p < 0.001).
NPI domains and cognitive status
In the total sample, more than 50% of the participants had at least one neuropsychiatric 
symptom (Table 2). The most frequent neuropsychiatric symptoms in the normal cognition 
group were sleep disturbances (30.3%), anxiety (25.6%), and depression (19.7%). In the 
mild/moderate cognitive impairment group, the most frequent neuropsychiatric symptoms 
were the same as in the normal control group, except that the proportion of those 
experiencing those symptoms was marginally higher: sleep alterations (37.1%), anxiety 
(34.7%), and depression (25.5%). Finally, the same symptoms were the most frequent in the 
severe cognitive impairment group, but depression was the most common (33.8%), followed 
by anxiety (28.2%) and sleep disturbances (25.7%). It is noteworthy that hallucinations were 
present in the three groups, but the higher occurrence was found in the group of severe 
cognitive impairment (21.1%).
Because neuropsychiatric symptoms tend to co-occur, we investigated the possibility of 
reducing the NPI data into clusters of symptoms. We used principal component analysis 
(Oblimin rotation) after testing for suitability of the data to proceed with factor analysis 
(Bartlett’s test of sphericity, p = 0.001, and Kaiser’s measure of sampling adequacy = 
0.62). Using the criterion of eigenvalues > 1.0, the 12 symptoms were reduced to five 
factors or components that explained 63.5% of the total variance in the data (Supplementary 
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Table 3). The first component (22.5% of total variance) denoted a dimension representing 
‘apathy’ and had high loadings on apathy, eating abnormalities, and aberrant motor behavior. 
The second component represented a ‘nighttime disturbances’ dimension, including 
nighttime disturbances and irritability. The third factor represented a ‘psychosis’ dimension, 
and had high loadings for delusions, hallucinations, and aberrant motor behavior. The 
fourth factor represented an ‘affective’ dimension and had high loadings on anxiety, 
depression, irritability, disinhibition, and agitation/aggression. The fifth factor represented 
a ‘hyperactivity’ dimension, and had high loadings of euphoria, agitation/aggression, and 
aberrant motor behavior. Because of three of the neuropsychiatric symptoms (aberrant motor 
behavior, agitation/aggression, and irritability) loaded in more than one component, we 
analyzed the association between each individual symptom in the different groups defined 
by cognitive status and adjusting for potential confounders.
After adjustment for sex, age, education, alcohol habits, obesity, serum glucose levels, serum 
total cholesterol levels, and hypertension, aberrant motor behavior (OR, 8.11; CI, 1.15–17.3; 
p = 0.036) and agitation/aggression (OR, 4.10; CI, 1.44–11.7; p = 0.008) were the main NPI 
domains related to cognitive status defined by MMSE and CDR scores (Table 3).
NPI domains and dementia
The most frequent neuropsychiatric symptoms in individuals clinically diagnosed as having 
dementia were anxiety (39.1%) and depression (38.9%), followed by sleep disturbances 
(34%), The dementia group showed a significantly higher frequency of aberrant motor 
behavior (p < 0.001), agitation/aggression (p < 0.001), delusions (p < 0.001), irritability (p < 
0.014), depression (p < 0.016), eating disorders (p < 0.012), and hallucinations (p = 0.033) 
than the dementia-free group (Fig. 1).
After accounting for potential confounders, the presence of aberrant motor behavior, 
agitation/aggression, delusions, irritability symptoms, an eating disturbance significantly 
associated with higher probability of having dementia by 4.25 (CI, 1.01–19.6; p = 0.043), 
6.22- (CI, 2.27–17.1; p < 0.001), 4.91-(95% CI 1.43–16.9; p = 0.012), 4.65 (CI, 1.81–12.0; p 
= 0.002), and 3.80 (CI, 1.42–10.0; p = 0.008) fold-increase; respectively (Fig. 2).
Area under the curve for cognitive status and dementia
Using the receiver-operating characteristics curve analysis, the addition of the 
neuropsychiatric symptoms collected with the NPI does not improve the sensitivity of the 
diagnosis of mild/moderate cognitive impairment. However, including the NPI significantly 
improves the discrimination of severe and cognitive impairment and dementia (Fig. 3). 
The inclusion of NPI scores in a basic model that accounted for sex, age, education, 
alcohol habits, obesity, serum glucose levels, serum total cholesterol levels, and conventional 
hypertension significantly improved the AUC from 0.93% to 0.95% for severe cognitive 
impairment (p < 0.003) and from 0.87% to 0.91% for dementia (p < 0.05).
DISCUSSION
Neuropsychiatric symptoms in older adults are frequent reasons for consultation in 
low resource settings. Because of its population base, sample size, and comprehensive 
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participant characterization, the MAS can provide insights into the prevalence of 
neuropsychiatric symptoms and its relationship to cognitive impairment in a Hispanic 
population, with low levels of education. We explored which of these symptoms were 
associated with mild/moderate and severe cognitive impairment and also if the recording of 
them with the NPI improves the sensitivity of a diagnosis based on global assessment tools 
(MMSE + CDR). Results confirmed higher rates of neuropsychiatric symptoms in the group 
with severe cognitive impairment and dementia, and intermediate prevalence among those 
with mild/moderate cognitive impairment in comparison with the normal cognition group.
We found that more than 50% of Hispanic cohort had at least one neuropsychiatric 
symptom. The prevalence estimates are comparable with prior population-based estimates, 
after considering some methodological differences [16–19]. Furthermore, the high 
prevalence of neuropsychiatric symptoms in the overall population was similar to the 
report by Salazar et al. (2015) [18]. In fact, out of the 12 symptoms, all but four were 
similar across all the cognitive groups, categorized either clinically or by global assessment 
measures. Sleep disturbances and anxiety were the most common symptoms in the normal 
cognition group affecting almost one third of participants, and not significantly different 
from the groups with cognitive impairment; this is similar to the reports of population-based 
cohorts in Spain [20] and Brazil [21]. Interestingly, disinhibition in the form of socially 
inappropriate comments and/or actions was barely reported, even within the group of severe 
cognitive impairment with an overall prevalence of 0.2%. It is possible that there is a cultural 
acceptance of age-related changes in the “freedom” of self-expression via speech or action, 
humor styles, or shame in reporting sexual disinhibition in this population.
After adjustment for potential confounders, none of the neuropsychiatric symptoms was 
significantly associated to mild/moderate cognitive impairment and only aberrant motor 
behavior and agitation/aggression were significantly associated with severe cognitive 
impairment. Aberrant motor behavior, such as s wandering away from home or repetitive, 
purposeless behaviors were present in about 2% of our cohort, reaching 8% in severe stages 
of cognitive impairment which is relatively lower than reported in Mexican-Americans [18] 
and others [22], but is relatively similar to the Brazilian report [21]. Agitation/aggression 
was found in about 9% of the cohort, but 18% among participants with severe cognitive 
impairment, this prevalence is almost half of what has been reported in Mexican Americans, 
but similar to the Brazilian report [21].
Consistently, addition of the neuropsychiatric symptoms added value to the global 
assessment strategy only for the diagnosis of severe cognitive impairment.
In terms of distinguishing features none of the neuropsychiatric symptoms was found 
to be more prevalent among those with mild/moderate cognitive impairment in contrast 
with the normal cognition group. After accounting for potential confounders, aberrant 
motor behavior, agitation/aggression, delusions, irritability and eating disturbance were 
significantly associated with dementia.
Improving precision of the clinical diagnosis is key to diminish the burden of dementia. 
The MMSE scores and cerebrospinal fluid (CSF)-tau levels are useful in the diagnosis of 
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AD [23]. If these two phenotypes are incorporated within the patient’s medical history, 
risk assessment, neuro-logical examination, and biomarkers such APOE genotype, there 
is approximately a 90% improvement of the dementia diagnosis [24]. However, the 
incorporation of neuropsychiatric, psychological, and behavioral symptoms might improve 
diagnostic accuracy, but data is scarce. We found that inclusion of NPI information 
significantly improved model performance of dementia diagnosis, as well as diagnosis of 
severe but not mild/moderate cognitive impairment.
Neuropsychiatric information is critical to the clinical management of dementias [25], 
which justified the inclusion of NPI profile into diagnostic approaches [3, 4]. Indeed, in 
individuals with MCI, the NPI profile improved the prediction of dementia progression 
[3,4]. However, these studies lack of Hispanics cohorts (0% from 6%). Based on our 
findings, the NPI profile might benefit the accuracy of dementia diagnosis in Hispanics. 
Interestingly, behavioral disturbances are more prominent compared to cognitive symptoms 
in the early-onset dementias, which may lead to missed cases or misdiagnosis [26]. 
Moreover, Watermeyer and Calia (2019) correctly note that the conceptual shift from 
cognitive aspects of AD to biological/biomarker-based approaches is challenging for low- 
and middle-income countries that may lack the resources and expertise to implement novel 
and costly diagnostic and intervention strategies [27].
Cognitive impairment was associated with the presence of neuropsychiatric symptoms in 
two NPI domains. Specifically, severe cognitive impairment was associated with aberrant 
motor behavior and agitation/aggression, which is usually linked with brain deterioration in 
more advanced stages of dementia [28]. Cummings et al. [11] reported positive correlations 
between MMSE scores and NPI delusions, anxiety, disinhibition, and aberrant motor 
behavior in non-Hispanic AD patients [10]. Interestingly, these authors also found that 
dementia-free control subjects with abnormal MMSE scores had higher NPI scores in their 
study, although they did not specify which NPI domains. Moreover, Royall and Palmer 
[29] recently reported that a latent dementia phenotype (δ) is associated with multiple 
behavioral and psychological disturbances, and that these associations are linked to general 
intelligence and not to domain-specific pathologies (e.g., domain-specific memory, executive 
function). The inclusion of Mexican-Americans in this study is commendable, and suggests 
that the relationship between cognitive function and psychological/behavioral disturbances 
in Hispanics/Latinos is an important topic that merits further study.
Our results are consistent with previous studies that examined neuropsychiatric symptoms in 
relation to cognitive status and dementia in non-Hispanic populations [3, 5]. For example, 
a study of elderly subjects in Minnesota found that MCI increased the prevalence of most 
NPI symptoms: 50% of individuals with MCI had at least one neuropsychiatric symptom, 
compared to 25% of those with normal cognition [16]. Another study of mostly Caucasian 
subjects in the US reported a relationship between neuropsychiatric symptoms and MCI, 
and also found that more subjects with dementia exhibited neuropsychiatric symptoms 
than non-demented individuals [30]. Our findings are particularly consistent with Salazar 
et al. [31] who reported that among individuals with AD, Mexican Americans had higher 
NPI behaviors than non-Hispanics; there were no differences between ethnic groups for 
individuals with clinically diagnosed MCI.
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The relationship between anxiety and cognitive impairment in dementias is complex and 
understudied [32]. For example, Scaricamazza et al. [33] reported higher anxiety scores 
associated with MCI than AD. Interestingly, in the present study, anxiety scores were highest 
in the moderate/mild cognitive impairment group (34.7%) compared to normal cognition 
(25.6%) and severe cognitive impairment (28.2%) groups. Ma [32] notes that anxiety 
has been studied less compared to depression; that results of various studies regarding 
anxiety-cognition interactions have been mixed, and that the concept of anxiety requires 
special consideration. Indeed, there are different types of anxiety [32], and others have 
proposed that anxiety interacts with other NPI domains. For example, Forrester et al. [4] 
used latent class analysis and found two behavioral clusters that contain anxiety: a severe 
cluster (anxiety with agitation) and an affective cluster (anxiety with depression). These 
results suggest that the relationship between anxiety and cognitive status in AD and related 
dementias is dependent on other psychological factors, and these interactions might impact 
mental health outcomes.
The present study must be interpreted within the context of its potential limitations. First, 
the cross-sectional design does not allow to infer causality, but rather associations between 
NPI domains, cognitive status, and dementia. Analysis of longitudinal data is needed to 
replicate our results in terms of risk-development of cognitive decline and dementia. The 
external validity of our findings will be corroborated with studies of the applicability of 
NPI instruments in other Hispanic populations. Second, the study included a low number 
of individuals with dementia at baseline. Given the longitudinal nature of the MAS, we 
would expect that in participants with normal cognitive status (defined by an MMSE above 
23 points), the presence of neuropsychiatry symptoms predicts the incidence of dementia. 
Third, we did not implement CSF or neuroimaging biomarkers in the diagnosis of dementia; 
however, the clinical diagnosis case is one of our study’s strengths. This study has several 
strengths to highlight and, given the longitudinal nature of the MAS, this cross-section 
analysis will help to define variables considered risk and confounders for follow up. Our 
multidisciplinary team encompassed physicians, including general practitioners, internal 
medicine, geriatrics, neuropsychiatry, neurologists, nurses, social workers, and psychologists 
for evaluation and analysis of the findings. Another strength of the MAS is the available 
data on cardiovascular risk factors. There is considerable evidence that cardiovascular risk 
factors, including hypertension or diabetes, are associated with psychosocial behavior and 
cognitive decline in the general population and patients with dementia [34, 35] and the 
development of dementia. We were then able to adjust our analyses by these two potential 
confounders. Finally, the MAS included Hispanic participants from a developing country. 
Although Hispanics share some sociocultural experiences and genetic/biological factors, 
Hispanics are not a monolithic group [36]. In fact, the prevalence of neuropsychiatric 
symptoms in Hispanics and Latinos in the US is influenced by familial country of origin 
[37]. Also, multicultural influences and local admixture might play a role in the observed 
results, and the possible between-group differences should be considered before aggregating 
data.
In conclusion, we found that neuropsychiatric symptoms relate to groups with variate 
cognitive impairment and dementia in Hispanic adults of the MAS, Venezuela. Our study 
provides new insight regarding the mental health status of a rapidly growing minority in 
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relation to dementia—one of the major public health diseases in older adults. Therefore, 
implementation of NPI instruments within the clinical practice might help identify and 
stratify patients at high risk of developing dementia. The general agreement of our findings 
with results of previous studies on non-Hispanic populations is encouraging, since Hispanics 
have been underrepresented in clinical research [38], and the similarity suggests that 
some findings might generally apply to different populations. Although longitudinal data 
are needed to replicate our results in terms of risk-development of cognitive decline 
and dementia, the applicability of NPI instruments in other populations supports the 
implementation of the assessment of neuropsychiatric symptoms in Hispanic populations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The proportion of neuropsychiatric symptoms in subjects with and without dementia at 
baseline. Neuropsychiatric Inventory (NPI). p-values are for the differences between groups.
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Association between NPI domains and dementia. NPI, Neuropsychiatric Inventory; OR, 
odds ratios; CI, confidence interval. Models accounted for sex, age, education, alcohol 
habits, obesity, serum glucose levels, serum total cholesterol levels, previous stroke, and 
conventional hypertension. Statistics were not computed for disinhibition due to absence of 
symptoms for these categories.
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Receiver Operating Characteristics Curve for Neuropsychiatric Inventory (NPI) to 
Discriminate Individuals with and without Mild-Cognitive (A), Severe Cognitive 
Impairment (B), and Dementia (C). AUC, area under the curve. Basic model accounted 
for sex, age, education, alcohol habits, obesity, serum glucose levels, serum total cholesterol 
levels, and conventional hypertension.
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